| Study name |
Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargE (ASPIRE) |
| Methods |
Randomised controlled trial |
| Participants |
Inclusion criteria:
Patients admitted to one of the study wards under supervision of a geriatrician A written informed consent by the patient or his/her representative Discharged from the hospital
Exclusion criteria:
Admitted for a maximum of one day Unable to understand Dutch Being in a palliative stage as stated in their medical record with active withdrawal of drug therapy Patients being discharged to another ward within the same hospital or to another hospital
|
| Interventions |
The interventional group receives a multifaceted clinical pharmacy intervention: (1) assessing patient and caregiver preferences, (2) medication reconciliation on admission, (3) comprehensive medication review before discharge, (4a) compiling a patient friendly medication list, (4b) optimising communication with healthcare providers in primary care, (4c) providing a copy of the medication list for the community pharmacist, (4d) contacting the general practitioner by phone, (4e) contacting, if applicable the home care nurse or the nurse from the nursing home by phone, (5) motivation interview before discharge with patients and caregivers, (6) post‐discharge follow‐up |
| Outcomes |
Primary outcome: time to all‐cause unplanned hospital visit after discharge (time frame: up to 6 months after discharge)
Secondary outcomes:
General practitioners contacts (time frame: up to 6 months after discharge) Mortality (time frame: up to 6 months after discharge) Number of planned hospital admissions, number of emergency department visits, number of unplanned hospital admissions (time frame: up to 6 months after discharge) Drug‐related readmissions (time frame: up to 6 months after discharge) Fall incidents (time frame: up to 1 month after discharge) Patient reported drug‐related problems (time frame: up to 1 month after discharge) Change in quality of life (EQ‐5D‐5L) (time frame: on admission, 1 month after discharge and 6 months after discharge) Differences in pain (NRS score) (time frame: up to 1 month after discharge) Number of medications (time frame: on admission, at discharge and 1 month after discharge) Medication adherence (time frame: on admission and 1 month after discharge) Potentially inappropriate medications (time frame: on admission, at discharge and 1 month after discharge) Cost‐effectiveness (time frame: up to 6 months after discharge)
|
| Starting date |
February 2021 |
| Contact information |
Julie Hias +3216343080. Email: julie.1.hias@uzleuven.be
|
| Notes |
Trial ID: NCT04617340
|
